Answers are grounded in this paper and cite their sources.
Purpose. Dry eye disease (DED) is a common ocular disorder with a potentially severe impact on patients' quality of life. Tear substitutes are the first-line treatment. The aim of this pilot study was to collect preliminary data concerning the efficacy and safety of a new liposome-based tear substitute -Lacrisek Ofta Plus -enriched with L-proline, L-glycine, L-lysine hydrochloride, and L-leucine as well as vitamin A and E.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: